DoH publishes revised agenda for July 2021 PBAC meeting

6 July 2021 - Agenda revised on the eve of next scheduled meeting. ...

Read more →

Roche withdraws submission for Avastin

28 March 2017 - Roche was seeking a positive CADTH recommendation for the use of bevacizumab in combination with pemetrexed ...

Read more →

AbbVie withdraws submission for Venclexta

10 January 2017 - Abbvie was seeking funding for venetoclax when used as a treatment for patients with chronic lymphocytic ...

Read more →

Revised CADTH procedure for voluntary withdrawal of a submission

25 February 2016 - Effective for all submissions and resubmissions targeting the April 2016 CDEC meeting and onward, manufacturers will have ...

Read more →